News

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 34.9% in the pre-market session after Novo Nordisk ...
Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of ...
In essence, Hims & Hers is embracing a "if you can't beat 'em, join 'em" approach that gives their customers more options.
Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers, Ro and LifeMD to sell Wegovy, as it looks to ...
Hims & Hers ( HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk ( NVO) announced a partnership with it and other telehealth platforms to offer patients access to the ...
A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.
It pains me to think I won’t be able to fully see my grandchildren’s faces and fully experience the biggest moments of my ...
Deals with Hims & Hers, LifeMD and Ro following a court's dismissal of a lawsuit challenging the FDA's determination Wegovy ...
Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...
Canada's Royal Bank of Canada will abandon its sustainable finance goals as industry practices for measuring and reporting ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
The stock (HIMS) soared 24.2% in midday trading toward a one-month closing high. It's on track the biggest one-day gain since it ran up 27.7% on Feb. 13, 2025. That rally was part of a big surge to ...